-
According to the June 4 data, India reported 4,302 active cases with an increase of 864 cases in the past 24 hours.
-
These companies now have until December 31, 2025, to comply with the improved manufacturing practices. The extension comes following requests from manufacturing units to upgrade their facilities, the ministry said in a statement.
-
The IMA has written to Union Health Minister J P Nadda drawing his attention to the growing concerns and uncertainty surrounding the delay in the NEET PG 2024 counselling process, which is currently held up due to an ongoing case in the Supreme Court.
-
Despite no positive cases reported at Pune's National Institute of Virology so far, the Health Ministry's advisory stressed the need for increased awareness, timely reporting, and preventive measures to mitigate public panic.
-
According to a gazette notification issued by the Union health ministry on August 12, the government has banned 'Aceclofenac 50mg + Paracetamol 125mg tablet', one of the popular combinations used as pain-relieving medicines manufactured by top pharma companies.
-
The proposal to include the EU in this list will be discussed at the upcoming meeting of the Drugs Technical Authority Board (DTAB), the highest advisory body on drugs in India under the drug regulator.
-
The most important flaw is that the authors have taken a subset of households included in the NFHS survey between January and April 2021, compared mortality in these households in 2020 with 2019, and extrapolated the results to the entire country, it said.
-
The 'Guidelines for Inter-Departmental Referral (within hospitals)' stress that referrals should be initiated promptly as and when patients require specialised care, diagnostic evaluations or consultations beyond scope of admitting department.
-
The Ministry of Ayush through its research council, the Central Council for Research in Ayurvedic Sciences (CCRAS) has taken this health initiative for Tribal Students in collaboration with the Ministry of Tribal Affairs and ICMR-NIRTH Jabalpur.
-
The Ministry of Health has decided to introduce a three-drug regimen for Pauci-Bacillary (PB) cases in place of a two-drug regimen for six months, according to the latest globally accepted scientific research studies and evidence-based practices.
-
Numerous meetings have been held on the issue of compliance of branding guidelines with all the states and union territories, including under the chairmanship of the Union health secretary, on March 31 and May 11 this year.
-
"The report further claims that some platforms have chosen less intrusive warnings as a result of such an agreement.
-
It also termed as "vague and ill-informed" media reports alleging shortage of anti-TB drugs in India and questioning the effectiveness of such drugs under the National TB Elimination Programme (NTEP).
-
G20 New Delhi Summit: The initiative will be rolled out on August 19 to consolidate efforts in the digital healthcare landscape around the world.
-
Call detail records (CDR) of one of the accused led the investigation team to a warehouse where the fake medicines were stored. The seizure found fakes of products of all top pharma companies. More raids are being planned.
-
On scanning the QR code, essential information such as manufacturing licence and batch number will facilitate the medicine’s authentication.
-
Uncertainty has dented investor confidence and legislation will help restore it, say the CEOs.
-
Acknowledging the shortage of specialist doctors in the country, a top health ministry official said the government has set a target of three years to bridge the existing gap
-
The NExT, scheduled for July 28, will be conducted by the All India Institute of Medical Sciences (AIIMS), Delhi.
-
The Internet and Mobile Association of India (IAMAI) has cautioned that the rules will significantly impact consumer viewing experience, and "throttle creativity and artistic expression".
-
The notification, published on World No Tobacco Day, mandates the OTT platforms to display anti-tobacco health spots for a minimum of thirty seconds each at the beginning and middle of the programme.
-
Despite penalties and imprisonment prescribed for offenders, E-cigarettes are available across a range of sources including tobacco vendors, general stores and online providers.
-
To check adulteration, the health ministry has started deliberations on testing drugs prior to export. However, the pharma industry has called for strengthening drug quality management and eschewing over-reliance on testing
-
According to the ministry, the national COVID-19 recovery rate has been recorded at 98.67 per cent, and the active cases currently make up 0.15 per cent of all reported cases.
-
In Maharashtra, the XBB 1.16 subvariant has been detected in 93 percent of COVID samples from Pune. The highly transmissible subvariant was also found in over 75 percent of COVID samples in Nagpur
